In this session, Christina Chambers, PhD, MPH, a perinatal epidemiologist from UC San Diego and Principal Investigator of MotherToBaby Pregnancy Studies, reviews what is known and what still requires further study on the use of alcohol, cannabis and …
Webinars: Substance Use Disorder
Fentanyl, Kratom and Xylazine: Perinatal Effect of New(er) and Emerging Substances of Concern
In the second webinar of a two-part series, Marcela Smid, MD, MS, MA, Associate Professor at the University of Utah and member of the Society for Maternal-Fetal Medicine (SMFM), explores the growing impact of emerging substances—fentanyl, kratom, and …
When Pregnancy, Substance Use Disorder and Mental Health Conditions Collide
Pregnancy is a critical time for identifying and managing co-occurring substance use disorders (SUD) and mental health conditions, yet these overlapping challenges are often underdiagnosed and undertreated. In the first installment of this two-part …
